Literature DB >> 8158963

Guidelines for the welfare of animals in rodent protection tests. A report from the Rodent Protection Test Working Party.

.   

Abstract

The rodent protection test (RPT) is used in antimicrobial research to confirm the in vivo efficacy of novel antibacterial, antiviral and antifungal agents. The RPT may involve lethal infection and thus has the potential to cause significant suffering. These Guidelines recommend refinements to the RPT which reduce animal use to a minimum and suggest cardinal clinical signs which act as predictors of lethality. Early recognition of these signs is imperative to minimize suffering, allow identification of humane end points and permit timely euthanasia. Constructive suggestions for the improvement of these Guidelines are welcomed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8158963     DOI: 10.1258/002367794781065870

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  9 in total

1.  A comparison of virulence patterns and in vivo fitness between hospital- and community-acquired methicillin-resistant Staphylococcus aureus related to the USA400 clone.

Authors:  M A Guimarães; M S Ramundo; M A Américo; M C de Mattos; R R Souza; E S Ramos-Júnior; L R Coelho; A Morrot; P A Melo; S E L Fracalanzza; F A Ferreira; A M S Figueiredo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-14       Impact factor: 3.267

2.  In vitro pharmacodynamic parameters of sordarin derivatives in comparison with those of marketed compounds against Pneumocystis carinii isolated from rats.

Authors:  P Aviles; E M Aliouat; A Martinez; E Dei-Cas; E Herreros; L Dujardin; D Gargallo-Viola
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

3.  Beyond Piperacillin-Tazobactam: Cefepime and AAI101 as a Potent β-Lactam-β-Lactamase Inhibitor Combination.

Authors:  Krisztina M Papp-Wallace; Christopher R Bethel; Jocelyne Caillon; Melissa D Barnes; Gilles Potel; Saralee Bajaksouzian; Joseph D Rutter; Amokrane Reghal; Stuart Shapiro; Magdalena A Taracila; Michael R Jacobs; Robert A Bonomo; Cédric Jacqueline
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

4.  Pharmacokinetics-pharmacodynamics of a sordarin derivative (GM 237354) in a murine model of lethal candidiasis.

Authors:  P Aviles; C Falcoz; R San Roman; D Gargallo-Viola
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

5.  Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105.

Authors:  Senad Divanovic; Aurelien Trompette; Sowsan F Atabani; Rajat Madan; Douglas T Golenbock; Alberto Visintin; Robert W Finberg; Alexander Tarakhovsky; Stefanie N Vogel; Yasmine Belkaid; Evelyn A Kurt-Jones; Christopher L Karp
Journal:  Nat Immunol       Date:  2005-04-24       Impact factor: 25.606

6.  Oral Passive Immunization With Plasma-Derived Polyreactive Secretory-Like IgA/M Partially Protects Mice Against Experimental Salmonellosis.

Authors:  Blaise Corthésy; Justine Monnerat; Marius Lötscher; Cédric Vonarburg; Alexander Schaub; Gilles Bioley
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

7.  Hypercapnia impairs lung neutrophil function and increases mortality in murine pseudomonas pneumonia.

Authors:  Khalilah L Gates; Heather A Howell; Aisha Nair; Christine U Vohwinkel; Lynn C Welch; Greg J Beitel; Alan R Hauser; Jacob I Sznajder; Peter H S Sporn
Journal:  Am J Respir Cell Mol Biol       Date:  2013-11       Impact factor: 6.914

8.  The ethical dimension in published animal research in critical care: the dark side of our moon.

Authors:  Olivier Huet; Judy B de Haan
Journal:  Crit Care       Date:  2014-03-13       Impact factor: 9.097

9.  Probiotic Properties of Alcaligenes faecalis Isolated from Argyrosomus regius in Experimental Peritonitis (Rat Model).

Authors:  A I Gutiérrez-Falcón; A M Ramos-Nuez; A Espinosa de Los Monteros Y Zayas; D F Padilla Castillo; M Isabel García-Laorden; F J Chamizo-López; F Real Valcárcel; F Artilles Campelo; A Bordes Benítez; P Nogueira Salgueiro; C Domínguez Cabrera; J C Rivero-Vera; J M González-Martín; J Martín Caballero; R Frías-Beneyto; Jesús Villar; J L Martín-Barrasa
Journal:  Probiotics Antimicrob Proteins       Date:  2021-03-13       Impact factor: 4.609

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.